November 15, 2016

Cyren Reports 2016 Third Quarter Financial Results

Quarterly Revenue Up 14% Year Over Year

MCLEAN, Va., Nov. 15, 2016 /PRNewswire/ -- Cyren (NASDAQ: CYRN) today announced its third quarter 2016 financial results for the period ending September 30, 2016.

"Cyren continued its strong momentum from the second quarter to deliver very solid third quarter results, translating to 14% year-over-year revenue growth, and the fifth straight quarter of increasing revenue," said Lior Samuelson, CEO and Chairman of the Board at Cyren. "Our investments in our enhanced cloud platform and sales and marketing are starting to have a significant impact as we receive more orders from enterprise customers for our SaaS security products, Cyren WebSecurity (CWS) and Cyren EmailSecurity (CES). Our embedded Threat Intelligence Services continue to generate a steady, reliable revenue stream and provide a massive amount of cyber-threat data, which improves our detection and prevention for all of our partners and enterprise customers."

In recent months, Cyren continued to demonstrate its leadership in the detection of advanced and unknown malware. The company was among the first to detect a new phishing attack variant that originated in the form of a Bitcoin-related pay-per-click advertising link using Google Adwords. The Cyren Security Lab continues to track Locky ransomware - identifying new encrypted downloads, new distribution methods (Microsoft Word macros and SWF files), and new payload delivery methods (executable malware and javascript). See more details on the Cyren blog at http://blog.cyren.com.

Cyren also released a special online Web Security Diagnostic tool. Designed for use by SMB and enterprise prospects, the tool allows web site visitors to easily check the efficacy of their existing web security solution in less than 30 seconds. The free online diagnostic tool tests for vulnerability to six common attack methods used by hackers to penetrate an organization's protection.

Third Quarter 2016 Financial Highlights:

  • Revenues for the third quarter of 2016 were $7.9 million, up 14% from $6.9 million for the third quarter of 2015, and an increase from $7.6 million for the second quarter of 2016. Q3 2016 represents the fifth successive quarter of revenue growth for Cyren.
  • Revenues for the nine months ended September 30, 2016 were $22.9 million compared to $20.7 million for the first nine months of 2015, representing an increase of 11% year over year.
  • GAAP net loss for the third quarter of 2016 was $1.0 million, compared to a net loss of $1.3 million in the third quarter of 2015.
  • GAAP net loss for the nine months ended September 30, 2016 was $3.3 million, compared to $3.6 million for the first nine months of 2015.
  • GAAP loss per basic and diluted share for the third quarter of 2016 was $0.02, compared to a loss of $0.04 for the third quarter of 2015.
  • Non-GAAP net loss for the third quarter of 2016 was $0.8 million, compared to a Non-GAAP net loss of $1.3 million for the third quarter of 2015.
  • Non-GAAP loss per basic and diluted share was $0.02 for the third quarter of 2016, compared to a Non-GAAP loss of $0.04 in third quarter of 2015.
  • Operating cash flow during the third quarter was $0.4 million, compared to operating cash flow of $0.6 million in the third quarter of 2015, and cash used by operating activities of $0.2 million during the second quarter of 2016.
  • Net cash usage during the third quarter was $0.5 million, compared to net cash usage of $1.1 million during the second quarter of 2016.
  • Cash balance as of September 30, 2016 was $12.4 million, compared to $13.0 million as of June 30, 2016. The company continues to have no debt.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Recent Business Highlights:

  • During the third quarter, the company released version 3.1 of Cyren WebSecurity, including improvements to SSL inspection and usability. The new release allows customers to whitelist certain categories of HTTPS traffic from inspection to ensure that employee privacy concerns are addressed. In addition, a number of enhancements were delivered around user reporting, end user block pages and emails, and Active Directory integration.
  • Cyren renewed several large-scale customer contracts, including a multi-year, multi-million dollar renewal with one of its largest customers using Cyren's Threat Intelligence Services.
  • Cyren expanded its global reach, establishing a multi-year distribution agreement with Jiransoft, a fast growing partner in South Korea. Jiransoft will resell Cyren's Threat Intelligence Services throughout South Korea, China, Taiwan and Japan.
  • To meet growing demand for cloud-based internet security services, Cyren has opened a new office outside of London, UK. The office will provide a focus for Cyren's EMEA sales and marketing efforts, complementing the company's security R&D labs in Germany and Israel.
  • In August, Cyren released its Q3 Cyberthreat Report that highlighted the increasing importance of phishing - which has become the industry's number one cybersecurity threat. The report identifies some of the most important trends in the evolution of phishing, including the best ways to stay protected from attacks. The Cyren Q3 Cyberthreat Report report can be downloaded by visiting http://pages.cyren.com/201608_Phishing_ThreatReport_LP.html.
  • Cyren's newly-released online web security diagnostic tool for SMBs and enterprise customers provides a free online test and downloadable report to analyze some of the most common web security gaps and vulnerabilities. The test, which can be run in less than 30 seconds from any web browser, checks whether the user's current web security solution allows the user to download common viruses, zipped viruses, or viruses over SSL, and whether the user is allowed to communicate with botnets, phishing sites, and anonymizer sites. Cyren's web security diagnostic tool can be accessed at: http://www.cyren.com/security-test.html.
  • Throughout the fourth quarter, Cyren is scheduled to participate in several investor conferences, including the 7th Annual Craig-Hallum Alpha Select Conference (November 16), the 13th Annual Imperial Capital Security Investor Conference (December 8), and the 2016 Cowan and Company Networking and Cybersecurity Summit (December 13-14). Visit the investor relations section of Cyren's website for more details.

Financial Results Conference Call:

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Tuesday, November 15, 2016.

US Dial-in Number:                       1-877-397-0286
Israel Dial-in Number:                  1-80-925-8243
International Dial-in Number:      1-719-325-4751

The call will be simultaneously webcast live on the investor relations section of Cyren's website at www.cyren.com/ir.html, or by using the following link: http://public.viavid.com/index.php?id=121724.

For those unable to participate in the live conference call, a replay will be available until November 29, 2016. To access the replay, the U.S. dial-in number is 1-844-512-2921 and the non-U.S. dial in number is 1-412-317-6671. Callers will be prompted for replay conference ID number 2397281. An archived version of the webcast will also be available on the investor relations section of the company's website.

About Cyren:

Cyren (NASDAQ and TASE: CYRN) protects more than 600 million users against cyber attacks and data breaches through its cloud-based web, email, mobile and endpoint security solutions. Relied upon by many of the world's largest technology companies such as Dell, Google, McAfee and Microsoft, Cyren offers enterprise-focused security as a service solutions as well as embedded solutions for software and security providers. Cyren's global cloud security platform processes more than 17 billion daily transactions and uses innovative zero-day protection technology to proactively block over 130 million threats each day. Learn more at www.cyren.com.

Blog: http://blog.cyren.com 
Facebook: www.facebook.com/CyrenWeb 
LinkedIn: www.linkedin.com/company/cyren 
Twitter: www.twitter.com/CyrenInc or www.twitter.com/cyren_ir  

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, executive termination costs, deferred taxes and deferred revenues related to acquisitions, one-time settlement agreements, reorganization expenses, adjustments to earn-out obligations and capitalization of technology. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements, including projections about the company's business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's Annual Reports on Form 20-F and reports on Form 6-K, which are available through www.sec.gov.

Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

Israel Investor Contact
Iris Lubitch
SmarTeam
+972.54.2528007
iris@smartteam.co.il 

Media Contact
Matthew Zintel
Zintel Public Relations
+1.281.444.1590
matthew.zintel@zintelpr.com 

 

CYREN LTD.









 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS









(in  thousands of U.S. dollars, except per share amounts)










Three months ended 


Nine months ended

September 30


September 30


2016


2015


2016


2015


Unaudited


Unaudited


Unaudited


Unaudited









 Revenues 

$    7,902


$    6,934


$  22,872


$  20,653









 Cost of revenues 

2,602


2,136


6,924


6,304









Gross profit 

5,300


4,798


15,948


14,349

















Operating expenses:
















 Research and development, net

2,091


2,166


6,512


6,674









 Sales and marketing 

2,618


2,094


7,559


6,533









 General and administrative 

1,515


1,895


4,983


4,604









 Adjustment of earn-out obligation

-


-


-


(77)









 Total operating expenses 

6,224


6,155


19,054


17,734









Operating loss

(924)


(1,357)


(3,106)


(3,385)









Other income (expenses)

(2)


(6)


5


(2)









Financial expense, net 

(68)


(92)


(201)


(375)









Loss before taxes

(994)


(1,455)


(3,302)


(3,762)









Tax benefit (expense)

19


125


(7)


114

















Net loss

$      (975)


$   (1,330)


$   (3,309)


$   (3,648)

















Loss per share - basic

$     (0.02)


$     (0.04)


$     (0.08)


$     (0.11)









Loss per share - diluted 

$     (0.02)


$     (0.04)


$     (0.08)


$     (0.11)









Weighted average number of shares outstanding: 








Basic 

39,132


35,205


39,125


32,696









Diluted  

39,132


35,205


39,125


32,696









 

CYREN LTD.









RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES









(in  thousands of U.S.dollars, except per share amounts)










Three months ended 


Nine months ended 


September 30


September 30


2016


2015


2016


2015


Unaudited


Unaudited


Unaudited


Unaudited









GAAP operating loss

$       (924)


$    (1,357)


$    (3,106)


$    (3,385)

Stock-based compensation (1)

250


251


747


784

Amortization of intangible assets (2)

784


402


2,018


1,170

Adjustment to earn-out liabilities (3)

-


-


-


(77)

Executive terminations (5)

30


-


87


-

Adjustment to deferred revenues (6)

-


42


66


127

Settlement agreements (7)

-


-


-


(628)

Capitalization of technology (8)

(839)


(557)


(2,245)


(1,062)




-





Non-GAAP operating loss

$       (699)


$    (1,219)


$    (2,433)


$    (3,071)









GAAP net loss

$       (975)


$    (1,330)


$    (3,309)


$    (3,648)

Stock-based compensation (1)

250


251


747


784

Amortization of intangible assets (2)

797


402


2,046


1,170

Adjustment to earn-out liabilities (3)

-


-


-


(29)

Amortization of deferred tax assets (4)

(66)


(82)


(216)


(247)

Executive terminations (5)

30


-


87


-

Adjustment to deferred revenues (6)

-


42


66


127

Settlement agreements (7)

-


-


-


(628)

Capitalization of technology (8)

(839)


(571)


(2,276)


(1,082)








-

Non-GAAP net loss

$       (803)


$    (1,288)


$    (2,855)


$    (3,553)









GAAP loss per share (diluted)

$      (0.02)


$      (0.04)


$      (0.08)


$      (0.11)

Stock-based compensation (1)

0.00


0.01


0.02


0.02

Amortization of intangible assets (2)

0.02


0.01


0.05


0.04

Adjustment to earn-out liabilities (3)

0.00


0.00


0.00


0.00

Amortization of deferred tax assets (4)

(0.00)


0.00


(0.00)


(0.01)

Executive terminations (5)

0.00


0.00


0.00


0.00

Adjustment to deferred revenues (6)

0.00


0.00


0.00


0.00

Settlement agreements (7)

0.00


0.00


0.00


(0.02)

Capitalization of technology (8)

(0.02)


(0.02)


(0.06)


(0.03)









Non-GAAP loss per share (diluted)

$      (0.02)


$      (0.04)


$      (0.07)


$      (0.11)









Numbers of shares used in computing non-GAAP loss per share (diluted)

39,132


35,205


39,125


32,696









(1) Stock-based compensation 








Cost of revenues 

$           24


$           15


$           51


$           48

Research and development 

77


73


243


210

Sales and marketing 

47


63


153


199

General and administrative 

102


100


300


327








-


$        250


$        251


$        747


$        784

(2) Amortization of intangible assets 








Cost of revenues 

$        596


$        208


$     1,452


$        587

Sales and marketing 

188


194


566


583

Financial expenses, net

13


-


28


-








-


$        797


$        402


$     2,046


$     1,170

(3) Adjustment to earn-out liabilities








General and administrative 

$              -


$              -


$              -


$         (77)

Financial expenses, net 

-


-


-


48








-


$              -


$              -


$              -


$         (29)

(4) Amortization of deferred tax assets








Tax benefit (expense)

$         (66)


$         (82)


$       (216)


$       (247)










$         (66)


$         (82)


$       (216)


$       (247)

(5) Executive terminations 








Sales and marketing 

$           30


$              -


$           87


$              -










$           30


$              -


$           87


$              -

(6) Adjustment to deferred revenues 








Revenues

$              -


$           42


$           66


$        127










$              -


$           42


$           66


$        127

(7) Settlement agreements








General and administrative 

$              -


$              -


$              -


$       (628)










$              -


$              -


$              -


$       (628)

(8) Capitalization of technology








Research and development

$       (839)


$       (557)


$    (2,245)


$    (1,062)

Financial expenses, net 

-


(14)


(31)


(20)










$       (839)


$       (571)


$    (2,276)


$    (1,082)

 

CYREN LTD.





CONDENSED CONSOLIDATED BALANCE SHEETS





(in thousands of U.S. dollars)










September 30


December 31


2016


2015


Unaudited


Audited





                 Assets




    Current Assets:




Cash and cash equivalents 

$          12,438


$         16,379

Trade receivables, net

3,685


3,849

Prepaid expenses and other receivables

1,009


949

 Total current assets 

17,132


21,177





Lease deposits 

340


79

Severance pay fund 

641


700

Property and equipment, net 

2,251


2,321

Goodwill and intangible assets, net

30,840


30,128

 Total long-term assets 

34,072


33,228

Total assets

$          51,204


$         54,405


(4,751.48)















                 Liabilities and Shareholders' Equity




    Current Liabilities:




Credit line

$                     -


$           4,169

Trade payables

653


603

Employees and payroll accruals 

2,284


2,500

Accrued expenses and other liabilities 

719


764

Earn-out consideration

2,411


2,346

Deferred revenues

5,049


3,269

 Total current liabilities 

11,116


13,651





Deferred revenues

2,387


824

Deferred tax liability

1,488


1,627

Accrued severance pay 

820


824

Other liabilities

134


131

Total long-term liabilities

4,829


3,406





Shareholders' equity 

35,259


37,348

Total liabilities and shareholders' equity

$          51,204


$         54,405

 

CYREN LTD.









 CONDENSED CONSOLIDATED CASH FLOW DATA









(in thousands of U.S. dollars)


















Three months ended 


Nine months ended 


September 30


September 30


2016


2015


2016


2015

Cash flows from operating activities:

Unaudited


Unaudited


Unaudited


Unaudited









Net loss

$     (975)


$  (1,330)


$  (3,309)


$  (3,648)









Adjustments to reconcile net loss to net cash provided by (used in) operating activities:








Loss on disposal of property and equipment

-


5


3


5

Depreciation 

312


333


955


982

Stock-based compensation

250


251


747


784

Amortization of intangible assets

797


401


2,046


1,169

Accrued interest, accretion of discount and exchange rate differences on credit line

-


1


(19)


66

Accretion and change in fair value of earn-out consideration, net

-


-


-


(29)

Deferred taxes, net

(57)


(64)


(177)


(188)









Changes in assets and liabilities:








Trade receivables

19


67


117


1,010

Prepaid expenses and other receivables

318


620


(45)


(469)

Change in long-term lease deposits

(33)


-


(261)


(133)

Trade payables

67


(229)


13


(8)

Employees and payroll accruals, accrued expenses and other liabilities

(380)


114


(266)


(578)

Deferred revenues

97


388


3,344


(219)

Accrued severance pay, net

13


7


55


49

Other long-term liabilities

-


-


(3)


-

Net cash provided by (used in) operating activities

428


564


3,200


(1,207)









Cash flows from investing activities:
















Proceeds from sale of property and equipment

-


5


-


5

Capitalization of technology

(839)


(571)


(2,276)


(1,082)

Purchase of property and equipment

(199)


(218)


(848)


(619)

Net cash used in investing activities

(1,038)


(784)


(3,124)


(1,696)









Cash flows from financing activities:
















Proceeds from public offering, net

-


11,785


-


11,632

Proceeds from credit line

-


-


-


4,400

Repayment of credit line

-


(327)


(4,150)


(5,200)

Payment of earn-out consideration

-


(457)


-


(457)

Proceeds from options exercised

71


-


71


153

Net cash provided by (used in) financing activities

71


11,001


(4,079)


10,528

Effect of exchange rate changes on cash and cash equivalents

9


14


62


(23)

Increase (decrease) in cash and cash equivalents

(530)


10,795


(3,941)


7,602

Cash and cash equivalents at the beginning of the period

12,968


7,870


16,379


11,063

Cash and cash equivalents at the end of the period

$ 12,438


$ 18,665


$ 12,438


$ 18,665

 

CYREN Logo. (PRNewsFoto/CYREN)

Logo - http://photos.prnewswire.com/prnh/20140120/SF48846LOGO  

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cyren-reports-2016-third-quarter-financial-results-300361686.html

SOURCE Cyren

News Provided by Acquire Media